Mining

Late-line metastatic cancer studies, by their nature, treat patients whose disease has progressed after multiple prior lines of therapy. These settings are notoriously difficult for demonstrating strong efficacy signals, both because the patient population is more heavily pretreated and because meaningful survival benefits are …

Chief Medical Officers play a central role in clinical-stage biotech companies, typically overseeing trial design, regulatory strategy, and the medical and scientific narrative the company presents to investors, physicians, and agencies like the FDA. A CMO departure ahead of major trial milestones can introduce …

Endoscopic sympathectomy refers to a minimally invasive procedure targeting the sympathetic nervous system, which regulates a wide array of involuntary bodily functions including heart rate, blood pressure, and pain signaling. Autonomix's platform is designed to combine sensing technology — which can detect and map …

PREA generally requires companies developing new drugs to study their safety and effectiveness in pediatric populations, but it also recognizes that testing unproven therapies in children before adult data are available can raise ethical and safety concerns, particularly for serious, high-mortality conditions like bacteremia. …

Feeding tube placement is a common but clinically important procedure, particularly for hospitalized patients who cannot safely take food or medication orally. Incorrect placement carries real risks, including tubes migrating into the airway rather than the digestive tract, which is why real-time navigation and …

Overall survival is widely considered the gold-standard endpoint in oncology clinical trials, since it directly measures whether a treatment helps patients live longer rather than relying on surrogate markers like tumor response rate or progression-free survival. A nearly nine-month improvement over historical benchmarks, if …

Severe alopecia areata remains a difficult-to-treat autoimmune condition in which the body's immune system attacks hair follicles, often leading to extensive and psychologically distressing hair loss. While JAK inhibitors from larger pharmaceutical companies have reshaped the treatment landscape in recent years, they carry boxed …